Endocrine Society Hires Haile-Selassie as Chief Financial Officer

Z Haile-Selassie Headshot

The Endocrine Society has hired Zerihun Haile-Selassie, CAE — a distinguished financial executive with more than 17 years of experience — to serve as its chief financial officer.

“I am honored to be joining the Endocrine Society, a nonprofit with a sterling reputation for responsible financial management,” Haile-Selassie says. “I am excited about the Society’s opportunities for continued long-term sustainable growth, diversified revenue, and international market expansion.”

Haile-Selassie is scheduled to start his new role on August 29.

Haile-Selassie most recently served as the chief financial officer of Inteleos, an internationally recognized medical certification organization. He previously was chief operating officer and chief financial officer at ACTFL, a nonprofit language association. Earlier in his career, he was a member of the finance leadership team at the American Israel Public Affairs Committee (AIPAC).

Haile-Selassie was named a Rising Star at the Nonprofit CFO of the Year Awards in 2018.

“Zerihun’s extensive experience strategically positioning nonprofit organizations for long-term growth aligns with the Society’s goals,” CEO Kate Fryer said. “We are eager to have him join the organization.”

Haile-Selassie earned his master’s degree in Accounting and Information Technology from the University of Maryland Global Campus and earned certification from Santa Clara University-Leavey School of Business’s Black Corporate Board Readiness program. 

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in